Advertisement

Topics

Otsuka America Pharmaceutical Incorporated Company Profile

13:50 EDT 24th September 2017 | BioPortfolio

Otsuka America Pharmaceutical, Inc. (OAPI) commercializes innovative pharmaceutical products in the U.S.

OAPI commercializes Otsuka-discovered and other healthcare products that serve unmet medical needs.

Location

2440 Research Boulevard
Rockville
MD
20850
United States of America

Contact

Phone: (301) 990-0030
Fax: (301) 212-8647
Email: mukeshp@otsuka.com


News Articles [1265 Associated News Articles listed on BioPortfolio]

M&As this week: Otsuka Pharmaceutical Factory, Sygnis

Otsuka Pharmaceutical Factory has signed an agreement to acquire 20% of outstanding shares in Otsuka Pharmaceutical India Private (OPI).

Otsuka Secures Exclusive Rights In Japan To Fremanezumab

PETAH TIKVA (dpa-AFX) - Otsuka Pharmaceutical Co., Ltd and Teva Pharmaceutical Industries, Ltd. (TEVA) announced an agreement covering Japan for Otsuka to develop and commercialize Teva's investig...

Otsuka, Teva collaborate to develop and commercialise fremanezumab for migraine

Otsuka Pharmaceutical Co and Teva Pharmaceutical Industries, Ltd, have announce an agreement covering Japan for Otsuka to develop and commercialize Teva's investigational drug candidate fremanezumab (...

Bipolar I disorder drug from Otsuka, Lundbeck gets FDA nod

The once-monthly, extended-release injectable Abilify Maintena, or aripiprazole, from Otsuka Pharmaceutical and H.  -More- 

Otsuka and Teva Sign Licensing Agreement for Japan on Prophylactic Migraine Drug Candidate Fremanezumab (TEV-48125)

Monday, May 15th 2017 at 12:00pm UTC TOKYO & JERUSALEM–(BUSINESS WIRE)– Otsuka Pharmaceutical Co., Ltd (Otsuka) and Teva Pharmaceutical Industries, Ltd. (Teva) announce an agreement co...

Mylan partners with Otsuka to commercialize tuberculosis med delamanid in high-burden countries

Subsidiaries of Mylan N.V. and Otsuka Pharmaceutical Co. ink an agreement to commercialize delamanid, branded as Deltyba by Otsuka, for the treatment of adults with pulmonary multidrug-resistant tuber...

Otsuka seeks FDA OK for antidepressant drug-device combo

A new-drug application has been resubmitted to the FDA by Otsuka Pharmaceutical for its antidepressant Abilify, or aripiprazo -More- 

Otsuka inks deal for rights to migraine drug candidate fremanezumab

Japan’s Otsuka Pharmaceutical has signed a deal to acquire rights to the investigational drug candidate…

PubMed Articles [1146 Associated PubMed Articles listed on BioPortfolio]

Critical review of surface-enhanced Raman spectroscopy applications in the pharmaceutical field.

Surface-enhanced Raman spectroscopy (SERS) is a sensitive analytical tool used in the pharmaceutical field in recent years. SERS keeps all the advantages of classical Raman spectroscopy while being is...

Pharmaceutical lobbying in Brazil: a missing topic in the public health research agenda.

In the US, where registration of lobbyists is mandatory, the pharmaceutical industry and private health-care providers spend huge amounts of money seeking to influence health policies and government d...

Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding.

Chapter issued by the United States Pharmacopeial Convention, Inc. is the standard for sterile compounding. It is designed to reduce the number of patient infections due to contaminated pharmaceutica...

The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel.

Change Pain Latin America (CPLA) was created to enhance chronic pain understanding and develop pain management improving strategies in this region. During its 7(th) meeting (August 2016), the main obj...

Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs?

Poorly soluble and/or permeable molecules jeopardize the discovery and development of innovative medicines. Pharmaceutical co-crystals, formed by an active pharmaceutical substance (API) and a co-crys...

Clinical Trials [562 Associated Clinical Trials listed on BioPortfolio]

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Bioequivalence Study of Bosiqing and ABILIFY Under Fasting/Fed Condition

To compare the rate and extent of absorption of Aripiprazole Orally disintegrating tablets 10 mg of Chengdu Kanghong Pharmaceutical Group Co.,Ltd, China and ABILIFY (Aripiprazole) 10 mg or...

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

The purpose of this study is to determine the safety and efficacy of Busulfan/FLAG (fludarabine, cytarabine and granulocyte colony-stimulating factor) Conditioning Regimen in Patients with...

Companies [2061 Associated Companies listed on BioPortfolio]

Otsuka America Pharmaceutical Incorporated

Otsuka America Pharmaceutical, Inc. (OAPI) commercializes innovative pharmaceutical products in the U.S. OAPI commercializes Otsuka-discovered and other healthcare products that serve unmet medical ne...

Otsuka America Pharmaceutical, Inc.

Otsuka America Pharmaceutical, Inc. (OAPI) is a successful, innovative, fast-growing healthcare company that commercializes Otsuka-discovered and other product opportunities in North America, with a s...

Otsuka Pharmaceutical Co., Ltd./H. Lundbeck A/S

Otsuka Pharmaceutical is a global healthcare company with the corporate philosophy: “Otsuka – people creating new products for better health worldwide.” Otsuka rese...

Otsuka Pharmaceutical Development & Commercialization, Inc. and Lundbeck U.S.

Otsuka Pharmaceutical Company is a global healthcare company with the corporate philosophy: “Otsuka–people creating new products for better health worldwide.” Otsuk...

Otsuka Canada Pharmaceutical Inc.

Founded in 1964, Otsuka Pharmaceutical Co., Ltd. is a global healthcare company with the corporate philosophy 'Otsuka-people creating new products for better health worldwide.â€...

More Information about "Otsuka America Pharmaceutical Incorporated" on BioPortfolio

We have published hundreds of Otsuka America Pharmaceutical Incorporated news stories on BioPortfolio along with dozens of Otsuka America Pharmaceutical Incorporated Clinical Trials and PubMed Articles about Otsuka America Pharmaceutical Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Otsuka America Pharmaceutical Incorporated Companies in our database. You can also find out about relevant Otsuka America Pharmaceutical Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record